about
Recent Advances in Bronchoscopic Treatment of Peripheral Lung CancersBronchial thermoplasty: Long-term safety and effectiveness in patients with severe persistent asthmaA phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions.Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013.A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma.Gene therapy for lung neoplasms.Point: should epidermal growth factor receptor mutations be routinely tested for in patients with lung cancer? Yes.Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function or clinical outcome.High yield of bronchoscopic transparenchymal nodule access real-time image-guided sampling in a novel model of small pulmonary nodules in canines.Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesotheliomaA live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune inductionThe Use of Indwelling Tunneled Pleural Catheters for Recurrent Pleural Effusions in Patients With Hematologic Malignancies: A Multicenter StudyTumors of the mediastinum.Checkpoint Blockade in Lung Cancer and Mesothelioma.Gene therapy for malignant pleural mesothelioma.Transbronchial needle injection: a systematic review of a new diagnostic and therapeutic paradigm.Malignant pleural mesothelioma: update on treatment options with a focus on novel therapies.Cytokine gene therapy for malignant pleural mesothelioma.Immunotherapy for non-small cell lung cancer: current concepts and clinical trials.Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype.Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection.Prognostic value of primary tumor FDG uptake for occult mediastinal lymph node involvement in clinically N2/N3 node-negative non-small cell lung cancer.Comparison of moderate versus deep sedation for endobronchial ultrasound transbronchial needle aspiration.The use of convex probe endobronchial ultrasound-guided transbronchial needle aspiration in a pediatric population: a multicenter study.Endoscopic lung volume reduction. An American perspective.Advances in pleural disease management including updated procedural coding.Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy.Stent-mediated gene delivery for site-specific transgene administration to the airway epithelium and management of tracheobronchial tumors.High Complication Rate after Introduction of Transbronchial Cryobiopsy into Clinical Practice at an Academic Medical Center.Secondary carina Y-stent placement for post-lung-transplant bronchial stenosis.Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters.Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion.A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses.Intrapulmonary IFN-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of bronchogenic adenocarcinoma of the lung.Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years.Immuno-gene therapy with interferon-beta before surgical debulking delays recurrence and improves survival in a murine model of malignant mesothelioma.Suramin inhibits the growth of malignant mesothelioma in vitro, and in vivo, in murine flank and intraperitoneal models.The role of immunosuppression in the efficacy of cancer gene therapy using adenovirus transfer of the herpes simplex thymidine kinase gene.Kinetics of soluble mesothelin in patients with malignant pleural mesothelioma during treatment.A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesothelioma.
P50
Q26747020-427FE17A-763E-4E89-BEBB-7D7DA7196791Q30409292-C7720A78-1E69-4CD4-9CFA-9EB10303BA6FQ33523445-6FD427F9-CDC2-4ADF-AFFD-26D888B943FCQ33782832-89AE47ED-4A7A-40DA-AEED-F2B7832C4973Q33923147-EEE68A43-39A8-4177-B836-6A14A0B3D411Q34569410-9B96CB17-9149-4002-9FBD-0EE855A72223Q34608108-5D5A9887-FB0F-41EB-A5EB-9EA3684E10C4Q34777050-77FC7021-EF49-4590-9BEA-29E7EA9658D9Q35294186-38E643BD-4FE0-4B09-A04B-3AFAD3922BA1Q35374660-26C21329-193C-4C7F-B0B5-04EEC84B9BE5Q35787391-3C02CDFF-A994-47D4-9169-E4A4E61C25BEQ36015469-32E77260-5942-446A-93DD-1A84C16F2E7CQ36291430-4CFF7254-3520-438D-9027-3C571A24D39CQ36295004-AC3D61AF-C52B-4870-B84A-49B46CB83B44Q36329839-BCA01F7F-BE44-4FFC-B5B2-1839DCC27BD3Q36404991-3B6F9EEE-BE21-49CE-94B5-EEC652ED3CD9Q36728254-B17A7A99-A2B8-4ED2-AFE0-75E360F16578Q36780530-652F93D5-81C7-45F4-8F2F-E90B9754CCADQ36852170-50535C10-AF6A-4FC2-AE1D-5124074B7FFDQ37229478-A4399235-CE3A-4ADF-BBE6-C599FEA582DEQ37742771-72577DB5-1B1D-484B-91BF-A29F399C9B4DQ38056607-6E1E17E4-FD68-482E-85EB-C96ED57A38FEQ38100842-E1970303-3480-40FF-90FB-7559DC42D5AEQ38138002-10255886-6FC5-4145-B33A-E274F5B0836CQ38173421-724767E1-45DD-43C9-B714-F392E1C85E42Q38236889-D1A41E79-F833-4190-BCE8-7366C386CE5DQ38416306-729C531C-E03A-4B57-BC8F-B67389F16D2CQ38947140-CAEE830C-1AC4-4569-9868-652B709C7558Q39148014-5EDC96A2-2D82-4371-8DB5-925A506E72ECQ39236935-073C7370-CE09-42BB-8220-1D63F8FC547FQ39372281-DC68E414-A87D-4B11-8779-5BBE8994C376Q39417909-A2B88C20-AD59-4256-BE98-397647F25D54Q40099218-277FD15F-52A6-427E-B521-EA111CEFF513Q40372805-EE750360-A228-4F3F-896D-9F82A8526E72Q40483522-50FFBC39-D55F-41E5-A83C-33D0B9CADE83Q40593964-C1E9C991-B896-4EF4-9557-11D9B520C011Q40611866-C158B624-14CA-40A6-8614-C02045F1D87EQ40974124-2CF46055-94AA-4B58-B8B7-55B8EB62A333Q44173242-FCA67B3A-1F0B-4AF1-AC20-F4B2F3AE485DQ44367914-68C4C730-2E90-4296-9EE4-7A33F123777D
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daniel Sterman
@ast
Daniel Sterman
@en
Daniel Sterman
@es
Daniel Sterman
@nl
Daniel Sterman
@sl
type
label
Daniel Sterman
@ast
Daniel Sterman
@en
Daniel Sterman
@es
Daniel Sterman
@nl
Daniel Sterman
@sl
prefLabel
Daniel Sterman
@ast
Daniel Sterman
@en
Daniel Sterman
@es
Daniel Sterman
@nl
Daniel Sterman
@sl
P106
P21
P31
P496
0000-0003-1249-0804